
Inside Telix: The Aussie guided nuclear missile for cancer
Radio-pharma biotech Telix is building on the success – and the cashflow – from its nuclear-guided prostate cancer tool to aim for new cancers, and new treatments. Subscribe to Forbes Australia for full access to this and all articles today Subscribe Already a subscriber? Sign In